Delphi Financial »

Cartesian Therapeutics shares owned by Delphi Financial

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Delphi Financial from 13F filings

Historical chart of Delphi Financial investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by Delphi Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by Delphi Financial

Quarter filed Position value Share count Share price at filing
2024-09-30 $355k 22k 16.12
2024-06-30 $595k 22k 27.01

More positions owned by Delphi Financial

Vanguard Total Stock Market E Total Stk Mkt (VTI)
Ishares 0-5 Year High Yield C 0-5yr Hi Yl Cp (SHYG)
Energy Transfer Com Ut Ltd Ptn (ET)
Janus Henderson Aaa Clo Etf Hendrson Aaa Cl (JAAA)
MPLX Com Unit Rep Ltd (MPLX)
Cnx Resources Corporation (CNX)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Microsoft Corporation (MSFT)
Cheniere Energy Com New (LNG)
Amazon (AMZN)
Chesapeake Energy Corp (CHK)
ClearBridge Energy MLP Fund (EMO)
Oxford Lane Cap Corp (OXLC)
Ishares Tr Mbs Etf (MBB)
Blackstone Mortgage Tr Note 5.500% 3/1 (Principal)

View all positions for Delphi Financial

Top funds holding Cartesian Therapeutics

BlackRock
Jpmorgan Chase & Co
Artal Group
MPM Oncology Impact Management
Ikarian Capital
Vanguard Group
State Street Corporation
Geode Capital Management
Logos Global Management
Nuveen Asset Management
Marshall Wace
Sphera Funds Management
Delphi Financial
Charles Schwab Investment Management
Renaissance Technologies

View all funds holding Cartesian Therapeutics